30’s Tablets with red vine leaf extract

FOR SOUTH AFRICAN RESIDENTS

About Antistax^® Product Information Antistax^® Tablets Double Fresh Gel

Antistax^® tablets help maintain leg vein health and offer effective relief by improving blood flow in your legs, and noticeably reducing pain and swelling¹.

Antistax^® comes in easy-to-take tablets containing an extract of red vine leaf AS 195 (Bio-Active Flaven) which is clinically proven to provide symptomatic relief of chronic venous insufficiency (CVI Syndrome)³.

The dosage of Antstax® tablets is:

Adults: Take one film coated tablet (360 mg) in the morning. The dose may be increased to two film coated tablets daily. Swallow tablets whole with water before breakfast.

Should the condition not improve within six weeks, please consult your medical practitioner.

Pack Sizes: Tablets 30's or 60's pack

More about Antistax^®

ANTISTAX® Active Leg tablets. Reg. no.:48/32.2/1076. Each tablet contains dry extract of red vine leaf AS 195 (4 - 6:1) 360 mg per tablet. For full prescribing information refer to the professional information approved by the South African Health Products Regulatory Authority (SAHPRA).

ANTISTAX® Double Fresh Gel contains Red Vine Leaf Extract. Western herbal. This unregistered medicine has not been evaluated by the SAHPRA for its quality, safety or intended use.

HCR: Imperial Market Access Healthcare SA (Pty) Ltd, 10 Skeen Boulevard, Bedfordview, Gauteng, 2007. Reg. no.: 2006/029994/07.

General contact information: info.mahsa.sm@dpworld.com Tel: 012 621 4300. For any quality or safety related queries, please contact Imperial Quality at Quality.healthcare.sm@dpworld.com or Imperial Medical at pvimperiallogistics@dpworld.com.

References: 1. Antistax PIL 2. Antistax Double Fresh Gel PIL 3. Kiesewetter H. Koscielny J, Kalus U et al. Efficacy of orally administered extract of red vine leaf AS 195 (folia vitis viniferae) in chronic venous insufficiency (stages I-II): a randomised, double-blind, placebo-controlled trial. Arzneim.-Forsch./Drug Res 2000;50(1):109-117. 4. Kalus U, Koscielny J, Grigorov A et al. Improvement of cutaneous microcirculation and oxygen supply in patients with Chronic Venous Insufficiency by orally administered extract of red vine leaves AS 195: a randomised, double-blind, placebo-controlled, crossover study. Drugs R&D 2004; 5(2): 63-71. 5. Nees S, Weiss DR, Reichenblach-Klinke E et al. Protective Effects of Flavonoids Contained in the Red Vine Leaf on Venular Endothelium against the Attack of Activated Blood Components in vitro. Arzneim.-Forsch./Drug Res. 2003;53(5):330-341. 6. (last accessed 12 December 2023) 7. Francoise Pitsch. Results of the DECIDE survey: appraisal of the predictive value for chronic venous disease of a symptom. Phlebolymphology Vol 18. No. 3. 2011 8. NCBI - WWW Error Blocked Diagnostic (last accessed 13 December 2023) 9. The Epidemiology of Chronic Venous Insufficiency and Varicose Veins by Jennifer L. Beebe-Dimmer, John R Pfeifer, Jennifer S. Engle and David Schottenfeld. March 2005 SAZA.ANTI.19.08.0315

Antistax® Tablets

More about Antistax®

Antistax^® Tablets

More about Antistax^®